Previous 10 | Next 10 |
2023-03-09 02:20:00 ET Summary Increasing selling pressure among biotech stocks is a major concern. While the market's intermediate-term path is still up, the short-term outlook is weakening. Beware higher volatility in March as healthcare sector selling pressure persists. ...
Summary We think healthcare companies are quite resilient during periods of inflation because their products are not substitutable and they deliver innovation. Healthcare has lagged behind many other areas in terms of its adoption of technology. We think, regardless of the market en...
REDMOND, Wash., March 01, 2023 (GLOBE NEWSWIRE) -- Pushpay (NZSX:PPH, ASX:PPH, 'Pushpay' or 'the Company'), the leading payments and engagement solutions provider for faith-based and non-profit sectors, today released its 2023 State of Church Technology report , an annual benc...
Summary We think value stocks can outperform as interest rates head higher. Regions and sectors help us find quality within value and growth at a reasonable price. Stocks slid after the Federal Reserve’s preferred inflation gauge showed persistently high inflation, reinforcing wh...
REDMOND, Wash., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Pushpay (NZSX:PPH, ASX:PPH, 'Pushpay' or 'the Company'), the leading payments and engagement solutions provider for mission-driven organizations, will host a webinar on International Women’s Day to help spark inspiration and provide...
Summary Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow. Passive investors seeking a defensive position might just purchase the VanEck Pharmaceutical ETF and call it a year. Consider shorting ...
Summary When I think about the lessons learned from 2022, I think the biggest lesson is valuations matter. I do think this is the most predicted recession that I've ever seen, certainly, in my career. Investors of all stripes, whether you're an asset allocator or a stock picker, I t...
Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...
Summary Last year’s market volatility was driven primarily by uncertainty over inflation and interest rates. In last year’s downturn, technology stocks were at the epicenter of market volatility. After years of steady gains, investors now acknowledge that technology stocks...
Summary We think that the bear market is coming to an end, as it must. The way to go is to invest in higher beta, or at least in more beaten down issues. PPH has done well over the last 365 days, even though the issue around regulatory developments may not have completely hit market...
News, Short Squeeze, Breakout and More Instantly...
VanEck Vectors Pharmaceutical ETF Company Name:
PPH Stock Symbol:
NASDAQ Market:
2024-07-13 20:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 22:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 00:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...